T/CAPC 014-2023 Active
T/CAPC 014-2023 Retail pharmacy operating for the treatment of psoriasis and providing pharmacy services for the drugs in the specification
Abstract
Scope: This document stipulates the requirements for personnel operating psoriasis treatment drugs in retail pharmacies, medication consultation, prescription review, medication evaluation and intervention, follow-up and other pharmaceutical services, as well as quality control and evaluation improvement; Main technical content: Retail pharmacies should fully recognize the current incurability of psoriasis and its serious impact on patients' quality of life, guide patients to use drugs correctly, solve the existing or potential medication problems in the process of drug treatment, as well as non-drug treatment and mental health-related issues, help patients establish treatment confidence, achieve the goals of controlling the disease, reducing comorbidities, maintaining long-term efficacy, and comprehensively improving patients' quality of life.
General Product Information
| Document Type | Group standards |
|---|---|
| Standard Status | Active |
| Standard Code | T/CAPC 014-2023 |
| ICS | Integrated services |
| Implement Date | 2023-11-29 |